Virginia Cancer Specialists (VCS) Research Facility, Virginia

closed

In June 2017, Virginia Cancer Specialists (VCS) opened a Phase I clinical research facility in Fairfax, Virginia. Research facility Fairfax, Northern Virginia, US June 2017 Virginia Cancer Specialists (VCS) In June 2017, Virginia Cancer Specialists (VCS) opened a Phase I clinical research facility in Fairfax, Virginia. The state-of-the-art facility will provide the space and equipment required to carry out early-stage drug development and advanced cancer trial programmes. It will also enhance VCS’s cancer research programme by improving its overall Phase I clinical capabilities. The clinical facility has a total floor space of 4,000ft² and includes four treatment chairs equipped with special heating and massage features. The site’s design provides a comfortable and peaceful environment while encouraging communication and bonding among patients. Each of the facility’s treatment areas can be closed with curtains to offer private space for the patients. Phase I clinical trials protocols often require patients to be present on-site for more than 12 hours. In such events, the facility can accommodate the resident’s family members and caregivers. Among the staff employed at the facility are a team of physicians, data coordinators, nurses and clinical research coordinators. The facility also employs pharmacists who can ensure strict adherence to testing standards and offer specialised nursing services round-the-clock to monitor patients. VCS established the Phase I clinical facility in order to realise its long-term objective of turning the site into an Immuno-Oncology Centre of Excellence. According to the company, Phase I clinical trials are usually only available at large academic research centres, and very few companies can offer Phase I services during the initial stages of drug development. The facility will allow VCS to focus on investigational immuno-oncology (I-O) trials while providing patients with access to promising new therapies. The latest advancement in cancer research,I-O therapies have proven tolerability and strong responses after the completion of treatment in the cancer community. VCS is a cancer care and research centre based in Northern Virginia that has been carrying out Phase I clinical trials since 2013. It has been offering cancer treatment facilities to patients for more than 40 years. The research centre has a total of nine offices across Northern Virginia, which aim to help achieve the best outcomes for patients. It also has a number of cancer specialists, including oncologists, haematologists, oncology nurses and oncology pharmacists. The addition of the new facility enhances the VCS’s ability to provide novel early-stage studies, while also allowing the company to carry out trials and focus on promising new advancements such as immunotherapy. Get industry leading news, data and analysis delivered to your inbox Give your business an edge with our leading industry insights.

High